The collaboration is funded by the Mayo Clinic Center for Individualized Medicine and led by the center’s medical director, Dr. Keith Stewart.
Under the agreement, healthy patients who participate in a Mayo Clinic research study will receive a whole-genome sequencing screening test through Veritas Genetics’ flagship product, myGenome. Mayo Clinic researchers will offer clinical feedback to the Veritas Genetics team.
Mayo Clinic, which will also become a Veritas shareholder, says it will use any revenue it receives as a result of the collaboration to support its nonprofit mission to drive healthcare.
More articles on data analytics & precision medicine:
Microsoft partners with Adaptive Biotechnologies to ‘decode’ immune systems with AI
Vanderbilt-Ingram Cancer Center enters precision medicine collaboration with Tempus
4 questions with PotentiaMetrics CEO Robert Palmer on personalized healthcare
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
